Diagnostic HYBRIDS announces the FDA clearance, for marketing under the 510(k) pre-notification process, of the Thyretain TSI Reporter BioAssay. Thyretain is an in vitro diagnostic use test that specifically detects auto-antibodies called thyroid stimulating immunoglobulins (TSI) in patient serum.
Read MoreEpocal Inc announces that it has received FDA clearance to market its new glucose test on the epoc Blood Analysis System. Glucose measurements are used for the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell tumors.
Read MoreAMDL Inc announces the inauguration of AMDL Diagnostics Inc (ADI), a new wholly-owned subsidiary that will focus on the research, development, manufacture and international sales of Onko-SureAMDL’s proprietary, regulatory approved in vitro diagnostic (IVD) cancer test.
Read MoreFocus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, today announced that its Influenza A H1N1 (2009) Real Time RT-PCR test is now available as a test kit for use by “high complexity” clinical laboratories in the US
Read MoreultiGEN Diagnostics Inc has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.
Read More